THE MOST COMMON HYPERTENSIVE DISORDERS IN PREGNANCY
DOI:
https://doi.org/10.67214/1e9jn547Keywords:
hypertension, pregnancy, gestational weekAbstract
Hypertensive disorders are the most common medical complications that can occur during pregnancy, with an incidence ranging between 5–10%. These disorders are the leading cause of maternal mortality worldwide.
Objective: The aim of this retrospective study is to analyze the two-years archives data of the University Clinic of Gynecology and Obstetrics (UC OF G&OB) at the Clinical Center "Mother Teresa" – Skopje, concerning the hypertensive disorders during pregnancy, and to determine the main causes for its development, as well as the potential for their prevention.
Materials and Methods: The methodology used for the development of this specialist paper is primarily research-based and analytical. The analytical approach is based on data obtained from the Archives of the UC OF G&OB. The research approach included survey interviews designed for gynecologists, which were conducted with 4 gynecologists. The survey consisted of several open-ended questions.
Results: The research concluded that gestational hypertension the most often appears in, or after the 37th gestational week. Severe forms of hypertensive diseases during pregnancy include preeclampsia, eclampsia and HELLP syndrome. Preeclampsia occurs in 2-7% of the cases, and it is the most common disorder in women pregnant for the first time. Obesity is a definitive risk factor for preeclampsia, and the risk increases as the body mass index rises, especially in pregnant women who gained 1kg per week during the third trimester.
Conclusions: The doctor or nurse who refers to the patient should consult with the physician at the perinatal center regarding the referral and appropriate treatment. All data regarding the severity of the case, including prenatal information and a detailed medical record, should be sent along with the patient. Blood pressure should be stabilized, and convulsions should be controlled.
Downloads
References
1. Report of the National High blood Presure Education program. Working group Report on high blood pressure in Pregnancy. Am J Obstet gynecol 2000; 183: S1.
2. Sibai BM. Diagnosis and Menagement of gestational hypertension and preeclampsia. Obsest Gynecol 2003; 102 :181.
3. Hauth JC, Ewell MG, Levine RL, et at: Pregnancy outcomes in healthy nulliparas women who subsequently developed hypertension. Calcium for preeclampsia prevention study group. Obstet Gynecol 2000; 95:24.
4. Barton JR, O’Brien JM, Bergauer NK,et al : Mild gestational Hypertension remote from term : progression and outcome. Am J Obstet Gynecol 2001; 184 :979.
5. ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002 Apr;77(1):67-75. PMID: 12094777.
6. Caritis S, Sibai B, Hauth J, et al: Low dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med 1998; 338 :701.
7. Knuist M, Bonsel GJ, Zondervan HA, Treffers PE: Intensification of fetal and maternal disorders. Int J Gynecol Obstet 1998; 61 :127.
8. Lin L, August P. Genetic thrombophilia’s and preeclampsia: a meta-analysis. Obstet Gynecol 2005; 105 :182.
9. O’ Brien TE, Ray JG, Chan WS: Maternal body mass index and risk of preeclampsia: a systematic overview, Epidemiology 2003; 14 :368.
10. Audibert F, Friedman SA, Frangieh AY, Sibai BM: Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996; 175:460.
11. Haddad B, Barton JR, Livingston JC, et al: Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2000; 183:444.
12. Van Pampus MG, Wolf H, Westenberg SM, et al: Maternal and perinatal outcome after expectant management of the
HELLP syndrome compared with preeclampsia without HELLP syndrome. Bur J Obstet Gynecol 1995; 102:111.
13. Abramovici D, Friedman SA, Mercer BM, et al: Neonatal outcome in severe preeclampsia at 24 to 36 weeks’ gestation. Does HELLP Chemolysis, elevated liver enzymes, and low platelet count) syndrome matter? Am J Obstet Gynecol 1999; 180:221.
14. Barton JR, Sibai BM: Diagnosis and management of HELLP syndrome. Clin Perinatol 2004; 31 :807.
15. Loureiro R, Leite CC, Kahhale S, et al: Diffusion imaging may predict reversible brain lesions in eclampsia and severe preeclampsia: Initial experience. Am J Obstet Gynecol 2003; 189:1350.
16. MacKay AP, Berg CJ, Atrash HK: Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001; 97:533.
17. Khedagi AM, Bello NA. Hypertensive Disorders of Pregnancy. Cardiol Clin. 2021 Feb;39(1):77-90. doi: 10.1016/j.ccl.2020.09.005. Epub 2020 Nov 2. PMID: 33222817; PMCID: PMC7720658.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright of their work and grant the Macedonian Journal of Anaesthesia the right of first publication.
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Authors are permitted to enter into separate, additional contractual arrangements for the non-exclusive distribution of the published version of the work, provided that its initial publication in this journal is acknowledged.
